Structural basis for nuclear hormone receptor DNA binding

Molecular and Cellular Endocrinology

Volumn 348, Issue 2, 2012, Pages 411-417

  Helsen, Christine ^a   Kerkhofs, Stefanie ^a   Clinckemalie, Liesbeth ^a   Spans, Lien ^a   Laurent, Michaël ^b   Boonen, Steven ^b   Vanderschueren, Dirk ^c   Claessens, Frank ^a  

^a Department Molecular Cell Biology   (Belgium)

^b Centre for Metabolic Bone Diseases   (Belgium)

^c Division of Experimental Medicine and Endocrinology   (Belgium)

Author keywords

Carboxy terminal extension; ChIP; Dimerization; DNA binding; Nuclear receptor

Indexed keywords

ANDROGEN RECEPTOR; CELL NUCLEUS RECEPTOR; CYSTEINE; DNA; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GLUCOCORTICOID RECEPTOR; HORMONE RECEPTOR; MINERALOCORTICOID RECEPTOR; NUCLEAR HORMONE RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOID X RECEPTOR ALPHA; RETINOID X RECEPTOR BETA; RETINOID X RECEPTOR GAMMA; UNCLASSIFIED DRUG; ZINC;

ALLOSTERISM; ALPHA HELIX; AMINO ACID SEQUENCE; CARBOXY TERMINAL SEQUENCE; DIMERIZATION; DNA BINDING; DNA RESPONSIVE ELEMENT; DNA STRUCTURE; GENETIC TRANSCRIPTION; HUMAN; LIGAND BINDING; MULTIGENE FAMILY; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; TRANSACTIVATION;

AMINO ACID MOTIFS; ANIMALS; BINDING SITES; DNA; HUMANS; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RESPONSE ELEMENTS; TRANSCRIPTIONAL ACTIVATION;

EID: 82655181898     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.07.025     Document Type: Review

References (81)

1. Adler A.J., Danielsen M., Robins D.M. Androgen-specific gene activation via a consensus glucocorticoid response element is determined by interaction with nonreceptor factors. Proc. Natl. Acad. Sci. USA 1992, 89:11660-11663.
2. Alen P., Claessens F., Verhoeven G., Rombauts W., Peeters B. The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription. Mol. Cell. Biol. 1999, 19:6085-6097.
3. Bledsoe R.K., Montana V.G., Stanley T.B., Delves C.J., Apolito C.J., McKee D.D., Consler T.G., Parks D.J., Stewart E.L., Willson T.M., Lambert M.H., Moore J.T., Pearce K.H., Xu H.E. Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell 2002, 110:93-105.
4. Bourguet W., Ruff M., Chambon P., Gronemeyer H., Moras D. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature 1995, 375:377-382.
5. Brzozowski A.M., Pike A.C., Dauter Z., Hubbard R.E., Bonn T., Engstrom O., Ohman L., Greene G.L., Gustafsson J.A., Carlquist M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 1997, 389:753-758.
6. Cato A.C., Henderson D., Ponta H. The hormone response element of the mouse mammary tumour virus DNA mediates the progestin and androgen induction of transcription in the proviral long terminal repeat region. EMBO J. 1987, 6:363-368.
7. Cato A.C., Skroch P., Weinmann J., Butkeraitis P., Ponta H. DNA sequences outside the receptor-binding sites differently modulate the responsiveness of the mouse mammary tumour virus promoter to various steroid hormones. EMBO J. 1988, 7:1403-1410.
8. Cato A.C., Weinmann J. Mineralocorticoid regulation of transcription of transfected mouse mammary tumor virus DNA in cultured kidney cells. J. Cell Biol. 1988, 106:2119-2125.
9. Centenera M.M., Harris J.M., Tilley W.D., Butler L.M. The contribution of different androgen receptor domains to receptor dimerization and signaling. Mol. Endocrinol. 2008, 22:2373-2382.
10. Chalepakis G., Postma J.P., Beato M. A model for hormone receptor binding to the mouse mammary tumour virus regulatory element based on hydroxyl radical footprinting. Nucleic Acids Res. 1988, 16:10237-10247.
11. Chandra, V., Huang, P., Hamuro, Y., Raghuram, S., Wang, Y., Burris, T.P., Rastinejad, F., 2008. Structure of the intact PPAR-gamma-RXR-alpha nuclear receptor complex on DNA. Nature 350-356.
12. Claessens F., Alen P., Devos A., Peeters B., Verhoeven G., Rombauts W. The androgen-specific probasin response element 2 interacts differentially with androgen and glucocorticoid receptors. J. Biol. Chem. 1996, 271:19013-19016.
13. Claessens F., Celis L., De Vos P., Heyns W., Verhoeven G., Peeters B., Rombauts W. Functional androgen response elements in the genes coding for prostatic binding protein. Ann. N. Y. Acad. Sci. 1993, 684:199-201.
14. De Vos P., Claessens F., Winderickx J., Van Dijck P., Celis L., Peeters B., Rombauts W., Heyns W., Verhoeven G. Interaction of androgen response elements with the DNA-binding domain of the rat androgen receptor expressed in Escherichia coli. J. Biol. Chem. 1991, 266:3439-3443.
15. Denayer S., Helsen C., Thorrez L., Haelens A., Claessens F. The rules of DNA recognition by the androgen receptor. Mol. Endocrinol. 2010, 24:898-913.
16. Denison S.H., Sands A., Tindall D.J. A tyrosine aminotransferase glucocorticoid response element also mediates androgen enhancement of gene expression. Endocrinology 1989, 124:1091-1093.
17. Doesburg P., Kuil C.W., Berrevoets C.A., Steketee K., Faber P.W., Mulder E., Brinkmann A.O., Trapman J. Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor. Biochemistry 1997, 36:1052-1064.
18. Dubbink H.J., Hersmus R., Verma C.S., van der Korput H.A., Berrevoets C.A., van Tol J., Ziel-van der Made A.C., Brinkmann A.O., Pike A.C., Trapman J. Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor. Mol. Endocrinol. 2004, 18:2132-2150.
19. Escriva Garcia H., Laudet V., Robinson-Rechavi M. Nuclear receptors are markers of animal genome evolution. J. Struct. Func. Genom. 2003, 3:177-184.
20. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science 1988, 240:889-895.
21. Gearhart M.D., Holmbeck S.M., Evans R.M., Dyson H.J., Wright P.E. Monomeric complex of human orphan estrogen related receptor-2 with DNA: a pseudo-dimer interface mediates extended half-site recognition. J. Mol. Biol. 2003, 327:819-832.
22. Germain P., Staels B., Dacquet C., Spedding M., Laudet V. Overview of nomenclature of nuclear receptors. Pharmacol. Rev. 2006, 58:685-704.
23. Green, S., Kumar, V., Krust, A., Walter, P., Chambon, P., 1986. Structural and functional domains of the estrogen receptor. Cold Spring Harb. Symp. Quant. Biol. 51(Pt. 2), 751-758.
24. Haelens A., Tanner T., Denayer S., Callewaert L., Claessens F. The hinge region regulates DNA binding, nuclear translocation, and transactivation of the androgen receptor. Cancer Res. 2007, 67:4514-4523.
25. Haelens A., Verrijdt G., Callewaert L., Christiaens V., Schauwaers K., Peeters B., Rombauts W., Claessens F. DNA recognition by the androgen receptor: evidence for an alternative DNA-dependent dimerization, and an active role of sequences flanking the response element on transactivation. Biochem. J. 2003, 369:141-151.
26. Haelens A., Verrijdt G., Callewaert L., Peeters B., Rombauts W., Claessens F. Androgen-receptor-specific DNA binding to an element in the first exon of the human secretory component gene. Biochem. J. 2001, 353:611-620.
27. Ham J., Thomson A., Needham M., Webb P., Parker M. Characterization of response elements for androgens, glucocorticoids and progestins in mouse mammary tumour virus. Nucleic Acids Res. 1988, 16:5263-5276.
28. 2- and COOH-terminal interaction. J. Biol. Chem. 2002, 277:25631-25639.
29. Heery D.M., Kalkhoven E., Hoare S., Parker M.G. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 1997, 387:733-736.
30. Hollenberg S.M., Weinberger C., Ong E.S., Cerelli G., Oro A., Lebo R., Thompson E.B., Rosenfeld M.G., Evans R.M. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 1985, 318:635-641.
31. Hu S., Yao G., Guan X., Ni Z., Ma W., Wilson E.M., French F.S., Liu Q., Zhang Y. Research resource: genome-wide mapping of in vivo androgen receptor binding sites in mouse epididymis. Mol. Endocrinol. 2010, 24:2392-2405.
32. Jakacka M., Ito M., Weiss J., Chien P.Y., Gehm B.D., Jameson J.L. Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway. J. Biol. Chem. 2001, 276:13615-13621.
33. Jensen E.V. On the mechanism of estrogen action. Perspect. Biol. Med. 1962, 6:47-59.
34. John S., Sabo P.J., Johnson T.A., Sung M.H., Biddie S.C., Lightman S.L., Voss T.C., Davis S.R., Meltzer P.S., Stamatoyannopoulos J.A., Hager G.L. Interaction of the glucocorticoid receptor with the chromatin landscape. Mol. Cell 2008, 29:611-624.
35. Kerkhofs, S., De Gendt, K., Clinckemalie, L., Dubois, V., Schuit, F., Vanderschueren, D., Boonen, S., Saunders, P.T.K., Verhoeven, G., Claessens, F., submitted for publication. A role for selective androgen response elements in epididymal development and male fertility.
36. Klein-Hitpass L., Tsai S.Y., Greene G.L., Clark J.H., Tsai M.J., O'Malley B.W. Specific binding of estrogen receptor to the estrogen response element. Mol. Cell. Biol. 1989, 9:43-49.
37. Klokk T.I., Kurys P., Elbi C., Nagaich A.K., Hendarwanto A., Slagsvold T., Chang C.Y., Hager G.L., Saatcioglu F. Ligand-specific dynamics of the androgen receptor at its response element in living cells. Mol. Cell. Biol. 2007, 27:1823-1843.
38. Knegtel R.M., van Tilborg M.A., Boelens R., Kaptein R. NMR structural studies on the zinc finger domains of nuclear hormone receptors. EXS 1995, 73:279-295.
39. Kolchanov N.A., Merkulova T.I., Ignatieva E.V., Ananko E.A., Oshchepkov D.Y., Levitsky V.G., Vasiliev G.V., Klimova N.V., Merkulov V.M., Charles Hodgman T. Combined experimental and computational approaches to study the regulatory elements in eukaryotic genes. Brief. Bioinform. 2007, 8:266-274.
40. Kumar R., Thompson E.B. The structure of the nuclear hormone receptors. Steroids 1999, 64:310-319.
41. Lee M.S., Sem D.S., Kliewer S.A., Provencal J., Evans R.M., Wright P.E. NMR assignments and secondary structure of the retinoid X receptor alpha DNA-binding domain. Evidence for the novel C-terminal helix. Eur. J. Biochem. 1994, 224:639-650.
42. Luisi B.F., Xu W.X., Otwinowski Z., Freedman L.P., Yamamoto K.R., Sigler P.B. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 1991, 352:497-505.
43. Mahony S., Mazzoni E.O., McCuine S., Young R.A., Wichterle H., Gifford D.K. Ligand-dependent dynamics of retinoic acid receptor binding during early neurogenesis. Genome Biol. 2011, 12:R2.
44. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R.M. The nuclear receptor superfamily: the second decade. Cell. 1995, 83:835-839.
45. Martinez A., Val P., Sahut-Barnola I., Aigueperse C., Veyssiere G., Lefrancois-Martinez A.M. Steroidogenic factor-1 controls the aldose reductase akr1b7 gene promoter in transgenic mice through an atypical binding site. Endocrinology 2003, 144:2111-2120.
46. Massie C.E., Adryan B., Barbosa-Morais N.L., Lynch A.G., Tran M.G., Neal D.E., Mills I.G. New androgen receptor genomic targets show an interaction with the ETS1 transcription factor. EMBO Rep. 2007, 8:871-878.
47. Meijsing S.H., Pufall M.A., So A.Y., Bates D.L., Chen L., Yamamoto K.R. DNA binding site sequence directs glucocorticoid receptor structure and activity. Science 2009, 324:407-410.
48. Melvin V.S., Harrell C., Adelman J.S., Kraus W.L., Churchill M., Edwards D.P. The role of the C-terminal extension (CTE) of the estrogen receptor alpha and beta DNA binding domain in DNA binding and interaction with HMGB. J. Biol. Chem. 2004, 279:14763-14771.
49. Miller J., McLachlan A.D., Klug A. Repetitive zinc-binding domains in the protein transcription factor IIIA from Xenopus oocytes. EMBO J. 1985, 4:1609-1614.
50. Moehren U., Denayer S., Podvinec M., Verrijdt G., Claessens F. Identification of androgen-selective androgen-response elements in the human aquaporin-5 and Rad9 genes. Biochem. J. 2008, 411:679-686.
51. Nemoto T., Ohara-Nemoto Y., Shimazaki S., Ota M. Dimerization characteristics of the DNA- and steroid-binding domains of the androgen receptor. J. Steroid Biochem. Mol. Biol. 1994, 50:225-233.
52. Parker M.G., Page M.J. Use of gene transfer to study expression of steroid-responsive genes. Mol. Cell. Endocrinol. 1984, 34:159-168.
53. Payvar F., DeFranco D., Firestone G.L., Edgar B., Wrange O., Okret S., Gustafsson J.A., Yamamoto K.R. Sequence-specific binding of glucocorticoid receptor to MTV DNA at sites within and upstream of the transcribed region. Cell. 1983, 35:381-392.
54. Pearce D., Matsui W., Miner J.N., Yamamoto K.R. Glucocorticoid receptor transcriptional activity determined by spacing of receptor and nonreceptor DNA sites. J. Biol. Chem. 1998, 273:30081-30085.
55. Perlmann T., Umesono K., Rangarajan P.N., Forman B.M., Evans R.M. Two distinct dimerization interfaces differentially modulate target gene specificity of nuclear hormone receptors. Mol. Endocrinol. 1996, 10:958-966.
56. Podvinec M., Kaufmann M.R., Handschin C., Meyer U.A. NUBIScan, an in silico approach for prediction of nuclear receptor response elements. Mol. Endocrinol. 2002, 16:1269-1279.
57. Powell E., Wang Y., Shapiro D.J., Xu W. Differential requirements of Hsp90 and DNA for the formation of estrogen receptor homodimers and heterodimers. J. Biol. Chem. 2010, 285:16125-16134.
58. Rastinejad F., Perlmann T., Evans R.M., Sigler P.B. Structural determinants of nuclear receptor assembly on DNA direct repeats. Nature 1995, 375:203-211.
59. Roemer S.C., Donham D.C., Sherman L., Pon V.H., Edwards D.P., Churchill M.E. Structure of the progesterone receptor-deoxyribonucleic acid complex: novel interactions required for binding to half-site response elements. Mol. Endocrinol. 2006, 20:3042-3052.
60. Roulet E., Fisch I., Junier T., Bucher P., Mermod N. Evaluation of computer tools for the prediction of transcription factor binding sites on genomic DNA. In Silico Biol. 1998, 1:21-28.
61. Schauwaers K., De Gendt K., Saunders P.T., Atanassova N., Haelens A., Callewaert L., Moehren U., Swinnen J.V., Verhoeven G., Verrijdt G., Claessens F. Loss of androgen receptor binding to selective androgen response elements causes a reproductive phenotype in a knockin mouse model. Proc. Natl. Acad. Sci. USA 2007, 104:4961-4966.
62. Scheidereit C., von der Ahe D., Cato A.C., Wenz M., Suske G., Carlson C., Bosshard H., Westphal H.M., Beato M. Protein-DNA interactions at steroid hormone regulated genes. Endocr. Res. 1989, 15:417-440.
63. Schoenmakers E., Alen P., Verrijdt G., Peeters B., Verhoeven G., Rombauts W., Claessens F. Differential DNA binding by the androgen and glucocorticoid receptors involves the second Zn-finger and a C-terminal extension of the DNA-binding domains. Biochem. J. 1999, 341(Pt 3):515-521.
64. Schwabe J.W., Chapman L., Finch J.T., Rhodes D. The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements. Cell. 1993, 75:567-578.
65. Schwabe J.W., Rhodes D. Beyond zinc fingers: steroid hormone receptors have a novel structural motif for DNA recognition. Trends Biochem. Sci. 1991, 16:291-296.
66. Steketee K., Ziel-van der Made A.C., van der Korput H.A., Houtsmuller A.B., Trapman J. A bioinformatics-based functional analysis shows that the specifically androgen-regulated gene SARG contains an active direct repeat androgen response element in the first intron. J. Mol. Endocrinol. 2004, 33:477-491.
67. Stender J.D., Kim K., Charn T.H., Komm B., Chang K.C., Kraus W.L., Benner C., Glass C.K., Katzenellenbogen B.S. Genome-wide analysis of estrogen receptor alpha DNA binding and tethering mechanisms identifies Runx1 as a novel tethering factor in receptor-mediated transcriptional activation. Mol. Cell. Biol. 2010, 30:3943-3955.
68. Tsai S.Y., Carlstedt-Duke J., Weigel N.L., Dahlman K., Gustafsson J.A., Tsai M.J., O'Malley B.W. Molecular interactions of steroid hormone receptor with its enhancer element: evidence for receptor dimer formation. Cell. 1988, 55:361-369.
69. van Royen M.E., Cunha S.M., Brink M.C., Mattern K.A., Nigg A.L., Dubbink H.J., Verschure P.J., Trapman J., Houtsmuller A.B. Compartmentalization of androgen receptor protein-protein interactions in living cells. J. Cell Biol. 2007, 177:63-72.
70. van Royen M.E., Farla P., Mattern K.A., Geverts B., Trapman J., Houtsmuller A.B. Fluorescence recovery after photobleaching (FRAP) to study nuclear protein dynamics in living cells. Methods Mol. Biol. 2009, 464:363-385.
71. Verrijdt G., Haelens A., Claessens F. Selective DNA recognition by the androgen receptor as a mechanism for hormone-specific regulation of gene expression. Mol. Genet. Metab. 2003, 78:175-185.
72. Verrijdt G., Schauwaers K., Haelens A., Rombauts W., Claessens F. Functional interplay between two response elements with distinct binding characteristics dictates androgen specificity of the mouse sex-limited protein enhancer. J. Biol. Chem. 2002, 277:35191-35201.
73. Verrijdt G., Schoenmakers E., Alen P., Haelens A., Peeters B., Rombauts W., Claessens F. Androgen specificity of a response unit upstream of the human secretory component gene is mediated by differential receptor binding to an essential androgen response element. Mol. Endocrinol. 1999, 13:1558-1570.
74. Verrijdt G., Schoenmakers E., Haelens A., Peeters B., Verhoeven G., Rombauts W., Claessens F. Change of specificity mutations in androgen-selective enhancers. Evidence for a role of differential DNA binding by the androgen receptor. J. Biol. Chem. 2000, 275:12298-12305.
75. Wang J.C., Derynck M.K., Nonaka D.F., Khodabakhsh D.B., Haqq C., Yamamoto K.R. Chromatin immunoprecipitation (ChIP) scanning identifies primary glucocorticoid receptor target genes. Proc. Natl. Acad. Sci. USA 2004, 101:15603-15608.
76. Wang Q., Li W., Liu X.S., Carroll J.S., Janne O.A., Keeton E.K., Chinnaiyan A.M., Pienta K.J., Brown M. A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Mol. Cell 2007, 27:380-392.
77. Weisz A., Coppola L., Bresciani F. Specific binding of estrogen receptor to sites upstream and within the transcribed region of the chicken ovalbumin gene. Biochem. Biophys. Res. Commun. 1986, 139:396-402.
78. White R., Lees J.A., Needham M., Ham J., Parker M. Structural organization and expression of the mouse estrogen receptor. Mol. Endocrinol. 1987, 1:735-744.
79. Wurtz J.M., Bourguet W., Renaud J.P., Vivat V., Chambon P., Moras D., Gronemeyer H. A canonical structure for the ligand-binding domain of nuclear receptors. Nat. Struct. Biol. 1996, 3:87-94.
80. Wyce A., Bai Y., Nagpal S., Thompson C.C. Research resource: the androgen receptor modulates expression of genes with critical roles in muscle development and function. Mol. Endocrinol. 2010, 24:1665-1674.
81. Zella L.A., Meyer M.B., Nerenz R.D., Lee S.M., Martowicz M.L., Pike J.W. Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription. Mol. Endocrinol. 2010, 24:128-147.